Sutro Biopharma, Inc. (STRO) NASDAQ
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 98.32M |
| Enterprise Value | 55.86M |
| P/E Ratio | -1.02 |
| PEG Ratio | -0.03 |
| Price/Sales Ratio | 3.78 |
| Price/Book Ratio | -2.86 |
| Enterprise/Revenue | 2.82 |
| Enterprise/EBITDA | -0.96 |
Fiscal Year
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | June 30, 2026 |
Profitability
| Profit Margin | -3.95 |
| Operating Margin | -3.1 |
AD
Management Effectiveness
| Return On Assets | -0.93 |
| Return On Equity | 1.85 |
Income Statement
| Revenue | 102.48M |
| Revenue/Share | 2.76 |
| Gross Profit | 95.16M |
| EBITDA | -145.65M |
| Net Income | -191.09M |
| Diluted EPS | -22.49 |
Balance Sheet
| Total Cash | 164.35M |
| Total Cash/Share | 9.92 |
| Total Debt | 10.78M |
| Total Debt/Equity | -0.1 |
| Current Ratio | 3.32 |
| Book Value Per Share | -6.23 |
Price History
| 52-Week Change | 83.81 |
| 52-Week High | 43.85 |
| 52-Week Low | 7.15 |
| Moving Average 50 Days | 24.06 |
| Moving Average 200 Days | 22.35 |
Statistics
| Average Volume | 327,559 |
| Shares Outstanding | 9.68M |
| % Held by Institutions | 99.75 |
Dividend And Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | 1:10 |
| Last Split Date | December 03, 2025 |
AD
